Eco-friendly Synthesis of benzyl 4-(((4-bromophenyl)sulfonamido)methyl)cyclohexane-1-carboxylate; Physical and Biological Evaluation

Document Type : Research Article

Authors

1 Department of Chemistry, Hafiz Hayat Campus, University of Gujrat, Gujrat, PAKISTAN

2 Department of Chemistry, University of Central Punjab, Lahore Campus, Lahore, PAKISTAN

3 Research Center for Modelling and Simulations, National University of Sciences and Technology, H-12 Islamabad, PAKISTAN

4 National Centre for Nuclear Research, Andrzeja Sołtana 7, 05-400 Otwock, POLAND

Abstract

Hydrotreating of heavy naphtha using highly active NiMo catalysts on Walnut shell Activated Carbon (NiMo-WAC) nanocatalysts is a new technology for clean fuel production. In this research, pyrolysis of the walnut shell as a scalable, low-cost, and high-yield method was used to synthesize chemically activated carbon in the presence of ZnCl2, as activating agent. To enhance the catalytic conversion, walnut shell active carbon was functionalized with HCL, HNO3, and H2SO4 to prepare NiMo-WAC1, NiMo-WAC2, and NiMo-WAC3 respectively. These nanocatalysts were synthesized through the incipient wetness impregnation method and characterized by X-Ray Diffraction (XRD), Fourier Transform InfraRed (FT-IR) spectroscopy, inductively coupled plasma-atomic emission spectroscopy (ICP), Field Emission Scanning Electron Microscope (FESEM), Brunauer–Emmett– grammed Reduction (TPR) techniques. CHNS (Eager 300 for EA1112) was used to study elemental analysis of the walnut shell feedstock used for active carbon synthesis. Different operating parameters including temperature, pressure, LHSV, and H2/feed (heavy naphtha) ratio for hydrodesulfurization (HDS) reaction were explored by evaluating NiMo-WAC nanocatalysts catalytic activity. HDS of heavy naphtha with 2491 ppm of sulfur in the operation condition of temperature: 290 °C, pressure: 30 bar, H2/oil: 100 NL/L, and LHSV: 3.3 h-1 showed considerably higher activity of NiMo-WAC2 nanocatalyst, less than 10 ppm in the product, than NiMo-γAl2O3 as a commercial and reference catalyst, maximum 104 ppm in the product, and this is economically valuable.

Keywords

Main Subjects

References

[1] Ball P., Chemistry: why Synthesize? Nature News, 528(7582): 327-329 (2015).
[2] Whitesides G M., Reinventing Chemistry, Angewandte Chemie International Edition, 54 (11): 3196-3209 (2015).
[3] Blakemore D.C., Castro L., Churcher I., Rees D.C., Thomas A.W., Wilson D.M., Wood A., Organic Synthesis Provides Opportunities to Transform Drug Discovery, Nature Chemistry, 10: 383-394 (2018).
[4] Gerry C.J., Schreiber S.L., Chemical Probes and Drug Leads from Advances in Synthetic Planning and Methodology, Nature Reviews Drug Discovery, 17: 333-352 (2018).
[5] Campos K.R., Coleman P.J., Alvarez, J.C., Dreher S.D., Garbaccio R.M., Terrett N.K., Tillyer R.D., Truppo M.D., Parmee E.R., The Importance of Synthetic Chemistry in the Pharmaceutical Industry, Science, 363: 1-8 (2019).
[6] Feng M., Tang B., Liang S., Jiang X., Sulfur Containing Scaffolds in Drugs: Synthesis and Application In Medicinal Chemistry, Current Topics in Medicinal Chemistry, 16: 1200-1216 (2016).
[7] Hussein E.M., Al-Rooqi M.M., Abd El-Galil S.M., Ahmed S.A., Design, Synthesis, and Biological Evaluation of Novel N 4-substituted Sulfonamides: Acetamides Derivatives as Dihydrofolate Reductase (DHFR) Inhibitors, BMC Chemistry, 13(91): 1-18 (2019).
[8] Hassan S A., Synthesis, Spectroscopic Study and Biological activity of some New Heterocyclic Compounds Derived from Sulfadiazine, Zanco Journal of Pure and Applied Sciences, 31(6): 92-109 (2019).
[9] Hassan S.A., Aziz D.M., Synthesis, in Vitro Antimicrobial Assay and Molecular Docking Studies of Some New Symmetrical Bis-Schiff Bases and their 2-Azetidinones, Zanco Journal of Pure and Applied Sciences, 33(2): 34-50. 2021
[10] Hassan S A., Aziz D M., Synthesis of New Series Bis-3-Chloro-β-Lactam Derivatives from Symmetrical Bis-Schiff Bases as Effective Antimicrobial Agents with Molecular Docking Studies, Science Journal of University of Zakho, 9: 128-137 (2021).
[11] Ali A., Reddy G K K., Cao H., Anjum S G., Nalam M N., Schiffer C A., Rana T M., Discovery of HIV-1 Protease Inhibitors with Picomolar Affinities Incorporating N-Aryl-Oxazolidinone-5-Carboxamides as Novel P2 ligands, Journal of Medicinal Chemistry, 49: 7342-7356 (2006)
[12] Li R., Kenyon G.L., Cohen F.E., Chen X., Gong B., Dominguez J.N., Davidson E., Kurzban G., Miller R.E., Nuzum E.O., In Vitro Antimalarial Activity of Chalcones and their Derivatives, Journal of Medicinal Chemistry, 38: 5031-5037 (1995).
[13] Abdel-Wahab B.F., Abdel-Aziz H.A., Ahmed E.M., Synthesis and Antimicrobial Evaluation of Some 1, 3-thiazole, 1, 3, 4-thiadiazole, 1, 2, 4-triazole, and 1, 2, 4-triazolo [3, 4-b][1, 3, 4]-thiadiazine Derivatives Including a 5-(benzofuran-2-yl)-1-phenylpyrazole Moiety, Monatshefte für Chemie-Chemical Monthly, 140: 601-605 (2009).
[14] Pietrzik C., Behl C., Concepts for the Treatment of Alzheimer's Disease: Molecular Mechanisms and Clinical Application, International Journal of Experimental Pathology, 86: 173-185 (2005).
[15] Raymond S.B., Treat L.H., Dewey J.D., McDannol N.J., Hynynen K., Bacskai B.J., Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models, PloS One, 3: e2175 (2008).
[16] Yar M., Arshad M., Farooq A., Gilani M A., Ayub K., Ejaz A., Kumar A., Ninomiya I., Synthesis and DPPH Scavenging Assay of Reserpine Analogues, Computational Studies and in Silico Docking Studies in AChE and BChE Responsible for Alzheimer's Disease, Brazilian Journal of Pharmaceutical Sciences, 51: 53-61 (2015).
[17] Apostolova L.G., Dinov I.D., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M., 3D Comparison of Hippocampal Atrophy in Amnestic Mild Cognitive Impairment and Alzheimer's Disease, Brain, 129: 2867-2873 (2006).
[18] Wang G., Cheng Q., Zhang S., Bai L., Zeng J., Cui P.J., Zhang T., Sun Z K., Ren R J., Deng Y L., Economic Impact of Dementia in Developing Countries: An Evaluation of Alzheimer-Type Dementia in Shanghai, China, Journal of Alzheimer's Disease, 15: 109-115 (2008).
[19] Gomberg M., Buchler C., The Preparation of Benzyl Esters and other Benzyl-Derivatives from Benzyl Chloride, Journal of the American Chemical Society, 42: 2059-2072 (1920).
[20] Abbasi M., Ilyas M., Sonia A., Shahwar D., Raza M., Khan K., Ashraf M., Afzal I., Ambreen N., Curcumin and its Derivatives: Moderate Inhibitors of Acetylcholinesterase, Butyrylcholinesterase and Trypsin, Scientia Iranica, 19: 1580-1583 (2012).
[21] Shahid S., Raza M A., Ur-Rehman S., Synthesis, Characterization and Antimicrobial Potential of Transition Metal Complexes of Triacetic Lactone, African Journal of Biotechnology, 8: 5116-5121 (2009).
[22] Danish M., Bibi A., Raza M.A., Noreen N., Arshad M.N., Aisri M A., Sulfonamide Derived Esters: Synthesis, Characterization, Density Functional Theory and Biological Evaluation through Experimental and Theoretical Approach, Acta Chimica Slovenica, 67: 785-798 (2020).
[23] Dege N., Raza M.A., Doğan O E., Ağar T., Mumtaz M.W., Theoretical and Experimental Approaches of New Schiff Bases: Efficient Synthesis, X-Ray Structures, DFT, Molecular Modeling and ADMET Studies, Journal of the Iranian Chemical Society, 18: 2345-2368 (2021).
[24] Danish M., Raza M A., Anwar U., Rashid U., Ahmed Z., Differential Functional Theory and Molecular Docking Studies of Newly Synthesized Carbamates, Journal of the Chinese Chemical Society, 66(11): 1408-1415 (2019).
[25] Danish M., Bibi A., Gilani K., Raza M.A., Ashfaq M., Arshad M.N., Asiri A.M., Ayub K., Antiradical, Antimicrobial and Enzyme Inhibition Evaluation of Sulfonamide Derived Esters, Synthesis, X-Ray Analysis and DFT Studies, Journal of Molecular Structure, 1175: 379-388 (2019).
[26] Wolff S., Grimwood D., McKinnon J., Turner M., Jayatilaka D., Spackman M., "Crystal Explorer" package, ver. 3.1. University of Western Australia, Perth, Australia (2013).
[27] Aisha, Raza M A., Sumrra S H., Javed K., Saqib Z., Maurin J K., Budzianowski A., Synthesis, Characterization and Molecular Modeling of Amino Derived Thiazolidinones as Esterase and Glucosidase Inhibitors, Journal of Molecular Structure, 1219: 128609 (2020).
[28] Sheldrick G M., A Short History of SHELX, Acta Crystallographica Section A, 64: 112-122 (2008).
[29] Ashfaq M., Arshad M N., Danish M., Asiri A M., Khatoon S., Mustafa G., Zolotarev P N., Butt R A., Şahin O., Synthesis and Description of Intermolecular Interactions in New Sulfonamide Derivatives of Tranexamic Acid, Journal of Molecular Structure, 1103: 271-280 (2016).
[30] Murugavel S., Vijayakumar S., Nagarajan S., Ponnuswamy A., Crystal Structure and DFT Studies of 4-(1-Benzyl-5-Methyl-1h-1, 2, 3-Triazol-4-Yl)-6-(3-Methoxyphenyl) Pyrimidin-2-Amine, Journal of the Chilean Chemical Society, 59: 2640-2646 (2014).
[31] Dwivedi A., Baboo V., Bajpai A., Fukui Function Analysis and Optical, Electronic, and Vibrational Properties of Tetrahydrofuran and its Derivatives: A Complete Quantum Chemical Study, Journal of Theoretical Chemistry, 345234 (2015).
[32] Raza M.A., Fatima K., Molecular Modeling Approach for Designing of Amino‐Derived Anti‐Alzheimer Agents: A Computational Study, Journal of Physical Organic Chemistry, 33: e4076 (2020).
[33] Sumrra S. H., Kausar S., Raza M A., Zubair M., Zafar M N., Nadeem M A., Mughal E U., Chohan Z H., Mushtaq F., Rashid U., Metal Based Triazole Compounds: Their Synthesis, Computational, Antioxidant, Enzyme Inhibition and Antimicrobial Properties, Journal of Molecular Structure, 1168: 202-211 (2018).
[34] Jensen F., "Introduction to Computational Chemistry". John Wiley & Sons Inc. (2017).
[35] Tang C L., "Fundamentals of Quantum Mechanics: for Solid State Electronics and Optics", Cambridge University Press (2005).
[36] Gotwals R., Sendlinger S., "A Chemistry Educator's Guide to Molecular Modeling". The North Carolina School of Science and Mathematics, Durham, NC (2007).

Files

Share

How to cite

Statistics